| Variable |
Mean (SD)* |
P-value** |
| Creatinine (mg/dL) |
|
0.002 |
| 1st evaluation |
1.81 (0.4) |
| 2nd evaluation |
2.21(0.46) |
| 3rd evaluation |
1.9 (1.17) |
| 90 days post-treatment |
1.77(0.27) |
| 180 days post-treatment |
1.80(0.33) |
| Urea (mg/dL) |
|
0.000 |
| 1st evaluation |
105.13(16.91) |
| 2nd evaluation |
97.80(15.89) |
| 3rd evaluation |
65.13(27.18) |
| 90 days post-treatment |
63.40(20.40) |
| 180 days post-treatment |
52.07 (9.98) |
| Hematocrit (%) |
|
0.000 |
| 1st evaluation |
28.72(4.18) |
| 2nd evaluation |
29.72(3.65) |
| 3rd evaluation |
34.94(3.50) |
| 90 days post-treatment |
37.73(2.57) |
| 180 days post-treatment |
38.76(1.72) |
| Leukocytes (mm3/dL) |
|
0.000 |
| 1st evaluation |
3.07(1.05) |
| 2nd evaluation |
4.51(3.27) |
| 3rd evaluation |
5.86(2.71) |
| 90 days post-treatment |
6.18(1.41) |
| 180 days post-treatment |
6.40(0.95) |
| Platelets (mm3/dL) |
|
0.000 |
| 1st evaluation |
110.33(88.18) |
| 2nd evaluation |
178.07(183.17) |
| 3rd evaluation |
163.00(72.02) |
| 90 days post-treatment |
177.00(18.13) |
| 180 days post-treatment |
183.07(11.88) |
| Serum albumin (mg/dL)† |
|
0.009 |
| 1st evaluation |
3.32(0.76) |
| 2nd evaluation |
3.74(0.37) |
| 90 days post-treatment |
3.87(0.34) |
| 180 days post-treatment |
3.99(0.27) |
|
n = 24 remission patients.
1st evaluation: day 1 of treatment with amphotericin or glucamine.
2nd evaluation: day 5 of treatment with amphotericin or day 10 with glucamine.
3rd evaluation: day 10 of treatment with amphotericin or day 20 with glucamine.
† Serum albumin was not measured at intermediate time points.
** Determined by Friedman ANOVA, the Wilcoxon test or ANOVA factor repetition
measurements.
Mean and SD* (Mean (Standard Deviation) of leukocytes and platelets were
divided by 1.000.
Categorial variables are reported as n (%) |
| Table 6: Laboratory data of 24 patients with post-transplant Visceral Leishmaniasis
in remission and up to 6 months post-transplantation. |
